ClearPoint Neuro Q1 revenue rises 43%, beats estimates

Clearpoint Neuro

13/05/2026 21:20

Overview

U.S. neuro devices firm's Q1 revenue rose 43% yr/yr, beating analyst expectations

Gross margin expanded to 64% from 60% yr/yr

Operating expenses rose 44% due to IRRAflow integration and higher personnel costs

Outlook

ClearPoint Neuro estimates 2026 revenue between $52.0 mln and $56.0 mln

Company expects cost synergies from IRRAflow integration to reduce cash burn in H2 2026

ClearPoint Neuro anticipates IRRAflow integration could be cash neutral for full year 2027

Result Drivers

IRRAFLOW INTEGRATION - Revenue growth was driven by the integration of IRRAflow products and team, contributing to higher neurosurgery navigation and access revenue

DEVICE AND NAVIGATION GROWTH - Neurosurgery navigation, therapy and access revenue rose 80% yr/yr, supported by additional IRRAflow sales and the introduction of 3.0 operating room navigation software

CAPITAL EQUIPMENT SALES - Capital equipment and software revenue increased 177% yr/yr due to more placements of navigation capital, IRRAflow control units, and Prism laser units

Company press release: ID:nACS9Lz32a

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
Beat
$12.10 mln
$11.97 mln (3 Analysts)
Q1 Gross Margin
64.00%
Q1 Operating Expenses
$16.20 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"

Wall Street's median 12-month price target for Clearpoint Neuro Inc is $20.00, about 58.2% above its May 12 closing price of $12.64

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)